Blocadren

   
Google
 
Web NewDrugInformation.com

Blocadren


Drug - Blocadren
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Timolol Maleate
Multiple ingredients are in alphabetical order.

Strength - 20MG
The potency of the active ingredient(s), Timolol Maleate. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Blocadren. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018017
The FDA assigned number to Blocadren. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Blocadren. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Blocadren was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Blocadren. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Blocadren is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck Research Laboratories Div Merck Co Inc
The full name of the firm holding legal responsibility for the new application of Blocadren.

Blocadren